COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)

Clinical Trial ID NCT00132899

PubWeight™ 1.76‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00132899

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004 14.78
2 The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002 3.71
3 Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999 3.34
4 Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995 2.21
5 Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. Gastroenterology 2013 1.90
Next 100